Clinical Trial Update: Bioequivalence Study of Nalfurafine Hydrochloride Orally Disintegrating Tablets on Fasting and Fed in Humans [NA]

View source ↗

Summary

A completed bioequivalence study of Nalfurafine hydrochloride orally disintegrating tablets evaluating fasting and fed conditions in humans was reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pruritus

Drugs mentioned

• Nalfurafine hydrochloride (nalfurafine hydrochloride)

Snippet

Sponsor: Shandong New Time Pharmaceutical Co., LTD | Conditions: Pruritus | NA | Status: COMPLETED